nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—HTR2C—endogenous depression	0.356	0.415	CbGaD
Escitalopram—SLC6A4—endogenous depression	0.295	0.344	CbGaD
Escitalopram—CYP2D6—endogenous depression	0.207	0.242	CbGaD
Escitalopram—SLC6A2—locus ceruleus—endogenous depression	0.00818	0.143	CbGeAlD
Escitalopram—SLC6A2—sympathetic nervous system—endogenous depression	0.00647	0.113	CbGeAlD
Escitalopram—SLC6A2—autonomic nervous system—endogenous depression	0.00435	0.0759	CbGeAlD
Escitalopram—Citalopram—HTR2C—endogenous depression	0.00312	0.415	CrCbGaD
Escitalopram—Citalopram—SLC6A4—endogenous depression	0.00259	0.344	CrCbGaD
Escitalopram—Citalopram—CYP2D6—endogenous depression	0.00182	0.242	CrCbGaD
Escitalopram—SLC6A3—brainstem—endogenous depression	0.0013	0.0227	CbGeAlD
Escitalopram—HTR2C—brainstem—endogenous depression	0.00126	0.022	CbGeAlD
Escitalopram—SLC6A3—forebrain—endogenous depression	0.00126	0.0219	CbGeAlD
Escitalopram—HTR2C—forebrain—endogenous depression	0.00121	0.0212	CbGeAlD
Escitalopram—SLC6A4—brainstem—endogenous depression	0.00119	0.0208	CbGeAlD
Escitalopram—SLC6A4—forebrain—endogenous depression	0.00115	0.0201	CbGeAlD
Escitalopram—CHRM1—forebrain—endogenous depression	0.00115	0.02	CbGeAlD
Escitalopram—SLC6A2—brainstem—endogenous depression	0.00105	0.0183	CbGeAlD
Escitalopram—SLC6A2—forebrain—endogenous depression	0.00101	0.0177	CbGeAlD
Escitalopram—ADRA1A—brainstem—endogenous depression	0.000976	0.017	CbGeAlD
Escitalopram—CHRM1—cardiovascular system—endogenous depression	0.000969	0.0169	CbGeAlD
Escitalopram—ADRA1A—forebrain—endogenous depression	0.000942	0.0165	CbGeAlD
Escitalopram—SLC6A3—midbrain—endogenous depression	0.000829	0.0145	CbGeAlD
Escitalopram—HTR2C—midbrain—endogenous depression	0.000802	0.014	CbGeAlD
Escitalopram—ADRA1A—cardiovascular system—endogenous depression	0.000796	0.0139	CbGeAlD
Escitalopram—SLC6A4—midbrain—endogenous depression	0.00076	0.0133	CbGeAlD
Escitalopram—HRH1—forebrain—endogenous depression	0.000729	0.0127	CbGeAlD
Escitalopram—SLC6A3—nervous system—endogenous depression	0.000682	0.0119	CbGeAlD
Escitalopram—SLC6A2—adrenal gland—endogenous depression	0.000678	0.0118	CbGeAlD
Escitalopram—SLC6A4—endocrine gland—endogenous depression	0.000667	0.0117	CbGeAlD
Escitalopram—CHRM1—endocrine gland—endogenous depression	0.000665	0.0116	CbGeAlD
Escitalopram—HTR2C—nervous system—endogenous depression	0.000659	0.0115	CbGeAlD
Escitalopram—SLC6A3—central nervous system—endogenous depression	0.000656	0.0115	CbGeAlD
Escitalopram—SLC6A3—cerebellum—endogenous depression	0.000642	0.0112	CbGeAlD
Escitalopram—HTR2C—central nervous system—endogenous depression	0.000634	0.0111	CbGeAlD
Escitalopram—ADRA1A—adrenal gland—endogenous depression	0.00063	0.011	CbGeAlD
Escitalopram—SLC6A4—nervous system—endogenous depression	0.000625	0.0109	CbGeAlD
Escitalopram—CHRM1—nervous system—endogenous depression	0.000622	0.0109	CbGeAlD
Escitalopram—SLC6A4—central nervous system—endogenous depression	0.000601	0.0105	CbGeAlD
Escitalopram—CHRM1—central nervous system—endogenous depression	0.000599	0.0105	CbGeAlD
Escitalopram—SLC6A2—endocrine gland—endogenous depression	0.000588	0.0103	CbGeAlD
Escitalopram—CYP2D6—brainstem—endogenous depression	0.000575	0.01	CbGeAlD
Escitalopram—CYP2D6—forebrain—endogenous depression	0.000555	0.00969	CbGeAlD
Escitalopram—CYP2C19—endocrine gland—endogenous depression	0.000553	0.00966	CbGeAlD
Escitalopram—SLC6A2—nervous system—endogenous depression	0.00055	0.00961	CbGeAlD
Escitalopram—ADRA1A—endocrine gland—endogenous depression	0.000546	0.00954	CbGeAlD
Escitalopram—SLC6A2—central nervous system—endogenous depression	0.00053	0.00925	CbGeAlD
Escitalopram—SLC6A3—brain—endogenous depression	0.000521	0.0091	CbGeAlD
Escitalopram—ADRA1A—nervous system—endogenous depression	0.000511	0.00893	CbGeAlD
Escitalopram—HTR2C—brain—endogenous depression	0.000504	0.0088	CbGeAlD
Escitalopram—ADRA1A—central nervous system—endogenous depression	0.000492	0.0086	CbGeAlD
Escitalopram—HRH1—adrenal gland—endogenous depression	0.000488	0.00852	CbGeAlD
Escitalopram—ADRA1A—cerebellum—endogenous depression	0.000481	0.0084	CbGeAlD
Escitalopram—SLC6A4—brain—endogenous depression	0.000478	0.00834	CbGeAlD
Escitalopram—CHRM1—brain—endogenous depression	0.000476	0.00831	CbGeAlD
Escitalopram—HRH1—endocrine gland—endogenous depression	0.000423	0.00739	CbGeAlD
Escitalopram—SLC6A2—brain—endogenous depression	0.00042	0.00734	CbGeAlD
Escitalopram—HRH1—nervous system—endogenous depression	0.000396	0.00691	CbGeAlD
Escitalopram—ADRA1A—brain—endogenous depression	0.000391	0.00683	CbGeAlD
Escitalopram—HRH1—central nervous system—endogenous depression	0.000381	0.00666	CbGeAlD
Escitalopram—CYP3A4—endocrine gland—endogenous depression	0.000327	0.00571	CbGeAlD
Escitalopram—CYP2D6—endocrine gland—endogenous depression	0.000322	0.00562	CbGeAlD
Escitalopram—CYP3A4—nervous system—endogenous depression	0.000306	0.00535	CbGeAlD
Escitalopram—HRH1—brain—endogenous depression	0.000303	0.00528	CbGeAlD
Escitalopram—CYP2D6—nervous system—endogenous depression	0.000301	0.00526	CbGeAlD
Escitalopram—CYP3A4—central nervous system—endogenous depression	0.000295	0.00515	CbGeAlD
Escitalopram—CYP2D6—central nervous system—endogenous depression	0.00029	0.00506	CbGeAlD
Escitalopram—CYP2D6—cerebellum—endogenous depression	0.000283	0.00495	CbGeAlD
Escitalopram—CYP2D6—brain—endogenous depression	0.00023	0.00402	CbGeAlD
Escitalopram—ADRA1A—G alpha (q) signalling events—OXT—endogenous depression	0.000175	0.00227	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—CRH—endogenous depression	0.000168	0.00217	CbGpPWpGaD
Escitalopram—HRH1—G alpha (q) signalling events—HTR2C—endogenous depression	0.000166	0.00215	CbGpPWpGaD
Escitalopram—CHRM1—G alpha (q) signalling events—HTR2C—endogenous depression	0.000166	0.00214	CbGpPWpGaD
Escitalopram—ADRA1A—G alpha (q) signalling events—HTR2C—endogenous depression	0.000163	0.00211	CbGpPWpGaD
Escitalopram—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000162	0.0021	CbGpPWpGaD
Escitalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00016	0.00207	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.00016	0.00206	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000159	0.00206	CbGpPWpGaD
Escitalopram—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000158	0.00204	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000157	0.00203	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—SLC6A4—endogenous depression	0.000156	0.00202	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000153	0.00198	CbGpPWpGaD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—COMT—endogenous depression	0.000151	0.00195	CbGpPWpGaD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—MAOA—endogenous depression	0.00015	0.00194	CbGpPWpGaD
Escitalopram—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000149	0.00193	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000149	0.00192	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000148	0.00191	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000146	0.00188	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—HTR7—endogenous depression	0.000137	0.00177	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000137	0.00176	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000133	0.00172	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000133	0.00171	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000131	0.0017	CbGpPWpGaD
Escitalopram—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00013	0.00169	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00013	0.00169	CbGpPWpGaD
Escitalopram—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00013	0.00168	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00013	0.00168	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000128	0.00166	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000128	0.00165	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000126	0.00163	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—ADM—endogenous depression	0.000124	0.0016	CbGpPWpGaD
Escitalopram—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00012	0.00155	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000118	0.00153	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000118	0.00152	CbGpPWpGaD
Escitalopram—HTR2C—G alpha (q) signalling events—HTR2A—endogenous depression	0.000118	0.00152	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000116	0.0015	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—COMT—endogenous depression	0.000116	0.0015	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—MAOA—endogenous depression	0.000115	0.00149	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.000115	0.00148	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000114	0.00147	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000114	0.00147	CbGpPWpGaD
Escitalopram—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.000113	0.00146	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000112	0.00145	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000112	0.00145	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000112	0.00144	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000111	0.00144	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00011	0.00143	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00011	0.00142	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00011	0.00142	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000108	0.00139	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—ADM—endogenous depression	0.000108	0.00139	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—ADM—endogenous depression	0.000107	0.00138	CbGpPWpGaD
Escitalopram—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000106	0.00137	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—ADM—endogenous depression	0.000106	0.00136	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000105	0.00136	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CRH—endogenous depression	0.000104	0.00134	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—OXT—endogenous depression	0.000104	0.00134	CbGpPWpGaD
Escitalopram—HRH1—G alpha (q) signalling events—HTR2A—endogenous depression	0.000102	0.00132	CbGpPWpGaD
Escitalopram—CHRM1—G alpha (q) signalling events—HTR2A—endogenous depression	0.000102	0.00131	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—HTR1A—endogenous depression	0.0001	0.00129	CbGpPWpGaD
Escitalopram—ADRA1A—G alpha (q) signalling events—HTR2A—endogenous depression	0.0001	0.00129	CbGpPWpGaD
Escitalopram—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	9.77e-05	0.00126	CbGpPWpGaD
Escitalopram—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	9.73e-05	0.00126	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	9.63e-05	0.00124	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	9.6e-05	0.00124	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	9.45e-05	0.00122	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	9.11e-05	0.00118	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	9.09e-05	0.00117	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	9.08e-05	0.00117	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CRH—endogenous depression	9.01e-05	0.00116	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—OXT—endogenous depression	9.01e-05	0.00116	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—OXT—endogenous depression	8.98e-05	0.00116	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CRH—endogenous depression	8.98e-05	0.00116	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	8.94e-05	0.00116	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—OXT—endogenous depression	8.84e-05	0.00114	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CRH—endogenous depression	8.84e-05	0.00114	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—COMT—endogenous depression	8.69e-05	0.00112	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—HTR1A—endogenous depression	8.67e-05	0.00112	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—HTR1A—endogenous depression	8.64e-05	0.00112	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—MAOA—endogenous depression	8.63e-05	0.00112	CbGpPWpGaD
Escitalopram—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	8.57e-05	0.00111	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—HTR1A—endogenous depression	8.51e-05	0.0011	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—HTR7—endogenous depression	8.47e-05	0.00109	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—HTR2C—endogenous depression	8.38e-05	0.00108	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—HTR2C—endogenous depression	8.35e-05	0.00108	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—HTR2C—endogenous depression	8.22e-05	0.00106	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—COMT—endogenous depression	8e-05	0.00103	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—MAOA—endogenous depression	7.94e-05	0.00103	CbGpPWpGaD
Escitalopram—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	7.89e-05	0.00102	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	7.88e-05	0.00102	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	7.85e-05	0.00101	CbGpPWpGaD
Escitalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	7.85e-05	0.00101	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	7.79e-05	0.00101	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	7.73e-05	0.000999	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—HTR7—endogenous depression	7.34e-05	0.000948	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—HTR7—endogenous depression	7.31e-05	0.000945	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—HTR7—endogenous depression	7.2e-05	0.00093	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—ADM—endogenous depression	7.01e-05	0.000906	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	6.9e-05	0.000891	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	6.8e-05	0.000879	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	6.75e-05	0.000872	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	6.73e-05	0.000869	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	6.62e-05	0.000855	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—ADM—endogenous depression	6.37e-05	0.000823	CbGpPWpGaD
Escitalopram—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	6.36e-05	0.000822	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	6.22e-05	0.000804	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—ADM—endogenous depression	6.08e-05	0.000785	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—ADM—endogenous depression	6.06e-05	0.000783	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—ADM—endogenous depression	5.96e-05	0.00077	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—HTR2A—endogenous depression	5.93e-05	0.000766	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CRH—endogenous depression	5.88e-05	0.000759	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—OXT—endogenous depression	5.88e-05	0.000759	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR1A—endogenous depression	5.66e-05	0.000731	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—POMC—endogenous depression	5.62e-05	0.000726	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—ADM—endogenous depression	5.52e-05	0.000713	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—ADM—endogenous depression	5.5e-05	0.000711	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—ADM—endogenous depression	5.41e-05	0.0007	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	5.39e-05	0.000696	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	5.37e-05	0.000694	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CRH—endogenous depression	5.34e-05	0.000689	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—OXT—endogenous depression	5.34e-05	0.000689	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	5.29e-05	0.000683	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—COMT—endogenous depression	5.23e-05	0.000675	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—MAOA—endogenous depression	5.19e-05	0.000671	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—POMC—endogenous depression	5.17e-05	0.000668	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	5.16e-05	0.000666	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—HTR2A—endogenous depression	5.14e-05	0.000664	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR1A—endogenous depression	5.14e-05	0.000664	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—HTR2A—endogenous depression	5.12e-05	0.000662	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—OXT—endogenous depression	5.09e-05	0.000658	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CRH—endogenous depression	5.09e-05	0.000658	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—OXT—endogenous depression	5.08e-05	0.000656	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CRH—endogenous depression	5.08e-05	0.000656	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—HTR2A—endogenous depression	5.04e-05	0.000651	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CRH—endogenous depression	5e-05	0.000646	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—OXT—endogenous depression	5e-05	0.000646	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR1A—endogenous depression	4.9e-05	0.000633	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR1A—endogenous depression	4.89e-05	0.000631	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR1A—endogenous depression	4.81e-05	0.000621	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR7—endogenous depression	4.78e-05	0.000618	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—POMC—endogenous depression	4.74e-05	0.000612	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR2C—endogenous depression	4.73e-05	0.000612	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR2C—endogenous depression	4.72e-05	0.00061	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR2C—endogenous depression	4.64e-05	0.0006	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CRH—endogenous depression	4.62e-05	0.000597	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—OXT—endogenous depression	4.62e-05	0.000597	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CRH—endogenous depression	4.61e-05	0.000595	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—OXT—endogenous depression	4.61e-05	0.000595	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CRH—endogenous depression	4.54e-05	0.000586	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—OXT—endogenous depression	4.54e-05	0.000586	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR1A—endogenous depression	4.45e-05	0.000575	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR1A—endogenous depression	4.44e-05	0.000573	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR1A—endogenous depression	4.37e-05	0.000564	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR7—endogenous depression	4.34e-05	0.000561	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR2C—endogenous depression	4.3e-05	0.000555	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR2C—endogenous depression	4.28e-05	0.000554	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR2C—endogenous depression	4.22e-05	0.000545	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR7—endogenous depression	4.15e-05	0.000536	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR7—endogenous depression	4.13e-05	0.000534	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—WASF2—endogenous depression	4.11e-05	0.000531	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—POMC—endogenous depression	4.1e-05	0.00053	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—POMC—endogenous depression	4.09e-05	0.000529	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR7—endogenous depression	4.07e-05	0.000526	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—POMC—endogenous depression	4.03e-05	0.00052	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—WASF1—endogenous depression	3.94e-05	0.000509	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR7—endogenous depression	3.76e-05	0.000486	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADM—endogenous depression	3.76e-05	0.000486	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR7—endogenous depression	3.75e-05	0.000485	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR7—endogenous depression	3.69e-05	0.000477	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—WASF2—endogenous depression	3.56e-05	0.00046	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—WASF2—endogenous depression	3.55e-05	0.000459	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—WASF2—endogenous depression	3.5e-05	0.000452	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—WASF1—endogenous depression	3.42e-05	0.000441	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—WASF1—endogenous depression	3.41e-05	0.00044	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—POMC—endogenous depression	3.38e-05	0.000437	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—WASF1—endogenous depression	3.35e-05	0.000433	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR2A—endogenous depression	3.35e-05	0.000433	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADM—endogenous depression	3.26e-05	0.000421	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADM—endogenous depression	3.25e-05	0.00042	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TPH1—endogenous depression	3.24e-05	0.000418	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADM—endogenous depression	3.2e-05	0.000413	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—OXT—endogenous depression	3.15e-05	0.000407	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CRH—endogenous depression	3.15e-05	0.000407	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR2A—endogenous depression	3.04e-05	0.000393	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR1A—endogenous depression	3.03e-05	0.000392	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPH1—endogenous depression	2.98e-05	0.000385	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR2A—endogenous depression	2.9e-05	0.000375	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR2A—endogenous depression	2.89e-05	0.000374	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR2A—endogenous depression	2.85e-05	0.000368	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—OXT—endogenous depression	2.73e-05	0.000353	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CRH—endogenous depression	2.73e-05	0.000353	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CRH—endogenous depression	2.72e-05	0.000352	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OXT—endogenous depression	2.72e-05	0.000352	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CRH—endogenous depression	2.68e-05	0.000346	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OXT—endogenous depression	2.68e-05	0.000346	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—POMC—endogenous depression	2.68e-05	0.000346	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR2A—endogenous depression	2.64e-05	0.000341	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR1A—endogenous depression	2.63e-05	0.00034	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR2A—endogenous depression	2.63e-05	0.00034	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR1A—endogenous depression	2.62e-05	0.000339	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR2A—endogenous depression	2.59e-05	0.000334	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR1A—endogenous depression	2.58e-05	0.000333	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR7—endogenous depression	2.57e-05	0.000332	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2C—endogenous depression	2.54e-05	0.000328	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2C—endogenous depression	2.53e-05	0.000327	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2C—endogenous depression	2.49e-05	0.000322	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TPH2—endogenous depression	2.45e-05	0.000317	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CACNB2—endogenous depression	2.45e-05	0.000317	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—POMC—endogenous depression	2.43e-05	0.000314	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—DPYD—endogenous depression	2.41e-05	0.000312	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—endogenous depression	2.32e-05	0.0003	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—endogenous depression	2.31e-05	0.000299	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—endogenous depression	2.28e-05	0.000294	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPH2—endogenous depression	2.26e-05	0.000292	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CACNB2—endogenous depression	2.26e-05	0.000292	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CACNA1C—endogenous depression	2.24e-05	0.00029	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR7—endogenous depression	2.22e-05	0.000287	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—DPYD—endogenous depression	2.22e-05	0.000287	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR7—endogenous depression	2.22e-05	0.000286	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR7—endogenous depression	2.18e-05	0.000282	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.16e-05	0.000279	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—endogenous depression	2.11e-05	0.000272	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—endogenous depression	2.1e-05	0.000271	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—endogenous depression	2.07e-05	0.000267	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.06e-05	0.000267	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2D6—endogenous depression	1.96e-05	0.000253	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPH1—endogenous depression	1.95e-05	0.000252	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR2A—endogenous depression	1.8e-05	0.000232	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—endogenous depression	1.56e-05	0.000201	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—endogenous depression	1.55e-05	0.000201	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—endogenous depression	1.53e-05	0.000197	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—COMT—endogenous depression	1.49e-05	0.000192	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MAOA—endogenous depression	1.48e-05	0.000191	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNB2—endogenous depression	1.48e-05	0.000191	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPH2—endogenous depression	1.48e-05	0.000191	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DPYD—endogenous depression	1.45e-05	0.000188	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—endogenous depression	1.44e-05	0.000185	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—COMT—endogenous depression	1.37e-05	0.000177	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MAOA—endogenous depression	1.36e-05	0.000175	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.35e-05	0.000174	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—endogenous depression	1.24e-05	0.000161	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—endogenous depression	1.24e-05	0.00016	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—endogenous depression	1.22e-05	0.000158	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.18e-05	0.000152	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—endogenous depression	9.61e-06	0.000124	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—COMT—endogenous depression	8.94e-06	0.000116	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MAOA—endogenous depression	8.88e-06	0.000115	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—endogenous depression	8.84e-06	0.000114	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—endogenous depression	5.78e-06	7.47e-05	CbGpPWpGaD
